РусскийEnglish (UK)
     
 

Новости

Ведущие научные сотрудники НИИ Атеросклероза приняли участие в крупном международном событии в области кардиологии - EAS Congress Prague, состоявшемся 23-26 апреля с общим числом делегатов 2500 человек.

Проблематика конгресса представлена ниже.

  • What is the key driver of atherosclerotic cardiovascular disease: cholesterol or inflammation/immune response?
  • New EAS Consensus Panel statement: LDL causes ASCVD
  • PCSK9 inhibition again
  • Novel approaches to managing triglycerides
  • Lifestyle: novel genetic insights
  • What's New in EAS FH Studies Collaboration?

Ниже приведена краткая информация о докладах и стендовых сообщениях наших сотрудников.

SIALYLATION OF HUMAN PLASMA LIPOPROTEINS AS A KEY DETERMINANT OF BIOLOGICAL FUNCTION >>

GENES ASSOCIATED WITH CHOLESTEROL ACCUMULATION IN MACROPHAGES (TRANSCRIPTOME ANALYSIS) >>

POLYUNSATURATED LIPID SPECIES OF HDL ARE MOST STRONGLY AFFECTED BY GENETIC APOLIPOPROTEIN A-I DEFICIENCY >>

Добавлены новые статьи:

 

1 Sensory Rhodopsin I and Sensory Rhodopsin II Form Trimers of Dimers in Complex with their Cognate Transducers.

Orekhov P, Bothe A, Steinhoff HJ, Shaitan KV, Raunser S, Fotiadis D, Schlesinger R, Klare JP, Engelhard M.

Photochem Photobiol. 2017 May;93(3):796-804. doi: 10.1111/php.12763.

 

2 The effect of maximal vs submaximal exertion on postprandial lipid levels in individuals with and without coronary heart disease.

Aronov DM, Bubnova MG, Perova NV, Orekhov AN, Bobryshev YV.

J Clin Lipidol. 2017 Mar - Apr;11(2):369-376. doi: 10.1016/j.jacl.2017.01.007. Epub 2017 Jan 18.

 

Добавлены новые статьи:

1

  Macrophages and Their Contribution to the Development of Atherosclerosis.

Bobryshev YV1,2,3, Nikiforov NG4,5, Elizova NV4,5, Orekhov AN4,5,6,7.

Results Probl Cell Differ. 2017;62:273-298. doi: 10.1007/978-3-319-54090-0_11.

 

2 Chemokines and Relevant microRNAs in the Atherogenic Process.

Chistiakov DA1, Orekhov AN2, Bobryshev YV3.

Mini Rev Med Chem. 2017 Apr 19. doi: 10.2174/1389557517666170419113211. [Epub ahead of print]

 

3 Nanocarriers in improving chemotherapy of multidrug resistant tumors: Key developments and perspective.

Chistiakov DA1, Myasoedova VA2, Orekhov AN3, Bobryshev YV4.

Curr Pharm Des. 2017 Apr 7. doi: 10.2174/1381612823666170407123941. [Epub ahead of print]

 

4 Origin and spread of human mitochondrial DNA haplogroup U7.

Sahakyan H1,2, Hooshiar Kashani B3, Tamang R4, Kushniarevich A1,5, Francis A6, Costa MD7,8, Pathak AK1,9, Khachatryan Z2, Sharma I10, van Oven M11, Parik J1,9, Hovhannisyan H2,12, Metspalu E1,9, Pennarun E1, Karmin M1, Tamm E1,9, Tambets K1, Bahmanimehr A2, Reisberg T1,9, Reidla M1,9, Achilli A3, Olivieri A3, Gandini F3, Perego UA3, Al-Zahery N3, Houshmand M13, Sanati MH13, Soares P8,14, Rai E10, Šarac J1,15, Šarić T1,15, Sharma V10, Pereira L8,16, Fernandes V7,8,16, Černý V17, Farjadian S18, Singh DP6, Azakli H19, Üstek D20, Ekomasova Trofimova N1,21,22, Kutuev I1,21, Litvinov S1,21, Bermisheva M21, Khusnutdinova EK21,22, Rai N6, Singh M6, Singh VK6, Reddy AG6, Tolk HV1, Cvjetan S15,23,24, Lauc LB15,25, Rudan P15,26, Michalodimitrakis EN27, Anagnou NP28,29, Pappa KI29,30, Golubenko MV31, Orekhov V32, Borinskaya SA32, Kaldma K1, Schauer MA33, Simionescu M33, Gusar V34, Grechanina E34, Govindaraj P6, Voevoda M35,36,37, Damba L35, Sharma S10, Singh L6, Semino O3, Behar DM1,38, Yepiskoposyan L2, Richards MB7,39, Metspalu M1, Kivisild T1,9,40, Thangaraj K6, Endicott P41, Chaubey G1, Torroni A3, Villems R1,9,42.

Sci Rep. 2017 Apr 7;7:46044. doi: 10.1038/srep46044.

 

На сайт добавлены новые статьи:

Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders.Alexander N. Orekhov, Ekaterina A. lvanova.

Cell-Based Models for Development of Antiatherosclerotic Therapies. Zakiev ER, Nikiforov NG, Orekhov AN.

На сайт добавлена новая статья: Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein. Zakiev ER, Sukhorukov VN, Ivanova EA, Orekhov AN.

На сайт добавлены новые статьи:

 

1 Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of patients' Blood: Development of Therapeutic Approaches to reduce blood Atherogenicity.

 

Nikiforov NG, Zakiev ER, Elizova NV, Sukhorukov VN, Orekhov AN.

Curr Pharm Des. 2017 Jan 24. [Epub ahead of print]

 

2 The phenomenon of atherosclerosis reversal and regression: Lessons from animal models.

 

Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV.

Exp Mol Pathol. 2017 Feb;102(1):138-145. doi: 10.1016/j.yexmp.2017.01.013. Epub 2017 Jan 17.

 

3 Use of Primary Macrophages for Searching Novel Immunocorrectors.

 

Nikiforov NG, Elizova NV, Bukrinsky M, Dubrovsky L, Makeev VJ, Wakabayashi Y, Liu P, Foxx KK, Kruth HS, Jin X, Zakiev ER, Orekhov AN.

Curr Pharm Des. 2017 Jan 25. [Epub ahead of print]